Neurological symptoms in female carriers of the fragile X mental retardation premutation gene

Archie Digital Collections

Show simple item record

dc.contributor.author Doerflinger, Melanie
dc.date.accessioned 2006-07-07T14:31:22Z
dc.date.available 2006-07-07T14:31:22Z
dc.date.issued 2006-07-07T14:31:22Z
dc.identifier.uri http://hdl.handle.net/2271/181
dc.description Neuroscience IV Room 1028 Dykes 3:48 PM Abstract 161 en
dc.description.abstract Fragile X syndrome (FXS) is caused by an expanded trinucleotide repeat in the fragile X mental retardation gene (FMR1). Premutation alleles (55-200 CGG repeats) of FMR1 are known to contribute to the fragile X phenotype through genetic instability and transmission of full mutation alleles (>200 repeats) to offspring. There is now mounting evidence that the premutation alleles themselves contribute to clinical involvement, including premature ovarian failure among females and a more recently discovered fragile X-associated tremor/ataxia syndrome (FXTAS) among older males. Although classic FXTAS is rarer in female carriers than male carriers, females commonly reported muscle pain, weakness, and numbness. The aim of this study was to document the prevalence of these neurological symptoms compared to controls. DESIGN: A retrospective study was conducted of premutation females and female controls over a period of 42 months. Data were obtained by reviewing medical charts and documenting self reported neuralgias and symptoms found on neurological exam. RESULTS: Medical charts were reviewed for 105 premutation females and 55 control females. The premutation females reported symptoms of sleep disturbance, muscle pain, numbness, tremor, and diagnoses of fibromyalgia and multiple sclerosis more often than control females. Premutation females also showed sensation deficits on neurological exam more often than controls. Ataxia on exam was equal between the two groups. CONCLUSION: There is increased neuralgia reported in female carriers of the premutation FMR1 gene. A better understanding of this may give some indication of the molecular involvement in the carrier status and the function of the FMR1 gene. en
dc.description.sponsorship Hagerman, Randi M.I.N.D. Institute, UC-Davis en
dc.format.extent 477696 bytes
dc.format.mimetype application/vnd.ms-powerpoint
dc.language.iso en_US en
dc.subject fragile X Syndrome en
dc.subject FXTAS en
dc.subject FMR1 en
dc.subject trinucleotide repeat en
dc.subject premutation en
dc.subject CGG-repeat en
dc.subject neuralgia en
dc.title Neurological symptoms in female carriers of the fragile X mental retardation premutation gene en
dc.type Presentation en

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Archie


Advanced Search

Browse

My Account

Statistics